Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorGülen, Dumrul
dc.contributor.authorMaas, S.
dc.contributor.authorJulius, H.
dc.contributor.authorWarkentin, P.
dc.contributor.authorBritton, H.
dc.contributor.authorYounos, İbrahim H.
dc.contributor.authorTalmadge, J. E.
dc.date.accessioned2022-05-11T14:42:10Z
dc.date.available2022-05-11T14:42:10Z
dc.date.issued2012
dc.identifier.issn1567-5769
dc.identifier.urihttps://doi.org/10.1016/j.intimp.2012.03.009
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9258
dc.description.abstractIn this study, we examined the effects of cryoprotectant, freezing and thawing, and adenovirus (Adv) transduction on the viability, transgene expression, phenotype, and function of human dendritic cells (DCs). DCs were differentiated from cultured peripheral blood (PB) monocytes following Elutra isolation using granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) for 6 days and then transduced using an Adv vector with an IL-12 transgene. Fresh, cryopreserved, and thawed transduced immature DCs were examined for their: 1) cellular concentration and viability; 2) antigenicity using an allogeneic mixed lymphocyte reaction (MLR); 3) phenotype (HLA-DR and CD11c) and activation (CD83); and 4) transgene expression based on IL-12 secretion. Stability studies revealed that transduced DCs could be held in cryoprotectant for as long as 75 min at 2-8 degrees C prior to freezing with little effect on their viability and cellularity. Further, cryopreservation, storage, and thawing reduced the viability of the transduced DCs by an average of 7.7%; and had no significant impact on DC phenotype and activation. In summary, cryopreservation, storage, and thawing had no significant effect on DC viability, function, and transgene expression by Adv-transduced DCs. (C) 2012 Elsevier B.V. All rights reserved.en_US
dc.description.sponsorshipNebraska Research Initiativeen_US
dc.description.sponsorshipThis research was funded through the Nebraska Research Initiative. None of the contributing authors has any financial conflict of interest.en_US
dc.language.isoengen_US
dc.publisherElsevier Science Bven_US
dc.identifier.doi10.1016/j.intimp.2012.03.009
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCryopreservationen_US
dc.subjectDendritic cellsen_US
dc.subjectAdenovirusen_US
dc.subjectStabilityen_US
dc.subjectViabilityen_US
dc.subjectMessenger-Rnaen_US
dc.subjectRecombinant Adenovirusen_US
dc.subjectMalignant-Melanomaen_US
dc.subjectProstate-Canceren_US
dc.subjectVaccinationen_US
dc.subjectAntigenen_US
dc.subjectGenerationen_US
dc.subjectEfficienten_US
dc.subjectP53en_US
dc.subjectImmunotherapyen_US
dc.titleCryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical useen_US
dc.typearticleen_US
dc.relation.ispartofInternational Immunopharmacologyen_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Mikrobiyoloji Ana Bilim Dalıen_US
dc.authorid0000-0002-7792-7459
dc.authorid0000-0002-6328-6056
dc.authorid0000-0002-8711-7820
dc.identifier.volume13en_US
dc.identifier.issue1en_US
dc.identifier.startpage61en_US
dc.identifier.endpage68en_US
dc.institutionauthorGülen, Dumrul
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid6602366586
dc.authorscopusid25632466600
dc.authorscopusid24463483600
dc.authorscopusid7006336302
dc.authorscopusid55173255200
dc.authorscopusid35175256600
dc.authorscopusid23493641400
dc.authorwosidGulen, Dumrul/A-5955-2017
dc.authorwosidYounos, Ibrahim H/F-9225-2015
dc.authorwosidTalmadge, James/AAF-7242-2020
dc.identifier.wosWOS:000304580200009en_US
dc.identifier.scopus2-s2.0-84859339453en_US
dc.identifier.pmid22465385en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster